本页面由Tiger Trade Technology Pte. Ltd.提供服务

Phoenix Biotech Acquisition Corp

5.85
0.0000
成交量:- -
成交额:3.44万
市值:3,647.23万
市盈率:-23.77
高:5.85
开:5.85
低:5.85
收:5.85
52周最高:12.80
52周最低:4.12
股本:623.46万
流通股本:93.83万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.2461
每股收益(LYR):-0.0297
净资产收益率:--
总资产收益率:-2.55%
市净率:-2.65
市盈率(LYR):-197.06

数据加载中...

2022/10/31

企业合并公告

425 - Prospectuses and communications, business combinations
2022/10/31

企业合并公告

425 - Prospectuses and communications, business combinations
2022/08/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/06

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/24

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/19

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/10/22

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/18

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/18

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/15

重要事件披露

8-K - Current report
2021/10/12

重要事件披露

8-K - Current report
2021/10/01

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/01

SEC问询函

CORRESP [Cover] - Correspondence
2021/09/28

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/09/21

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933